Background on Medline and its Significance
Medline, a leading global medical supply company founded in 1966 by brothers Jon and Jim Mills, made its public debut on the Nasdaq stock exchange on Wednesday. The company’s shares opened at $35 each, but quickly surged to close the day at $40.66 per share, marking a 40.21% increase from its initial public offering (IPO) price of $29.
Medline’s Valuation and Impact
The IPO valued Medline at an impressive $46 billion, making it the largest IPO in the United States since Rivian’s 2021 stock market debut. Medline sold 216 million shares to raise $6,260 million in an expanded offering, setting a new record for private capital-backed IPOs.
Medline’s Business and Growth
Medline manufactures and distributes a wide range of medical supplies, including gloves, masks, scalpels, and wheelchairs. The company competes with industry giants like McKesson and Cardinal Health, consistently reporting annual sales growth since its inception. Medline has weathered economic cycles and the COVID-19 pandemic, demonstrating resilience and adaptability.
Delayed IPO Plans
Initially planned for this year, Medline’s IPO was postponed due to uncertainties surrounding tariffs on Asian-imported goods. Despite this setback, the company successfully completed its Nasdaq debut, showcasing investor confidence in Medline’s business model and future prospects.
Global Context and Medline’s Performance
Medline’s Nasdaq debut also marks the largest IPO globally in 2025, surpassing China’s CATL’s $5.3 billion offering in Hong Kong in May, according to data compiled by the London Stock Exchange Group (LSEG).
Financial Performance
In the first nine months of 2022, Medline reported net income of $977 million on revenues of $20.6 billion, compared to net income of $911 million on revenues of $18.7 billion in the same period the previous year.
Key Questions and Answers
- What is Medline? Medline is a global medical supply company founded in 1966 by Jon and Jim Mills. It manufactures and distributes a wide range of medical products, including gloves, masks, scalpels, and wheelchairs.
- Why is Medline’s IPO significant? Medline’s IPO is the largest in the United States since Rivian’s 2021 stock market debut and sets a new record for private capital-backed IPOs. It also marks the largest global IPO of 2025, surpassing CATL’s Hong Kong offering.
- What challenges did Medline face before its IPO? Medline’s initial IPO plans were delayed due to uncertainties surrounding tariffs on Asian-imported goods.
- How has Medline performed financially? In the first nine months of 2022, Medline reported net income of $977 million on revenues of $20.6 billion, demonstrating consistent growth since its founding.
